GE HealthCare Technologies Quarterly Income Statement
NASDAQ: GEHCHealth CareMedical ElectronicsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GE HealthCare Technologies revenue and earnings
In the quarter ended Mar 31, 2026, GE HealthCare Technologies generated $5.13 billion in revenue, up 7.4% from the same quarter a year earlier. Net income was $389.0 million (-31.0% year over year), for a net margin of 7.6% versus a median of 10.3% in the prior 5 quarters. Gross margin was 38.5% (down from 42.1%) and operating margin 10.0%.
Diluted earnings per share came in at $0.85, down from $1.23.
Summary generated from market data by MetaCap's automated system. Methodology
GE HealthCare Technologies income statement (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.13B | 5.70B | 5.14B | 5.01B | 4.78B | 5.32B | 4.86B | 4.84B | 4.65B | 5.21B | 4.82B | 4.82B |
| Revenue growth (YoY) | +7.41% | +7.13% | +5.76% | +3.47% | +2.73% | +2.17% | +0.85% | +0.46% | -1.21% | +5.43% | +5.38% | +7.43% |
| Gross Profit | 1.98B | 2.26B | 1.99B | 1.99B | 2.01B | 2.27B | 2.03B | 2.00B | 1.90B | 2.16B | 1.94B | 1.94B |
| Operating Expenses | 1.46B | 1.43B | 1.34B | 1.33B | 1.38B | 1.47B | 1.35B | 1.40B | 1.36B | 1.47B | 1.32B | 1.37B |
| Research & Development | 345.00M | 323.00M | 292.00M | 302.00M | 344.00M | 344.00M | 316.00M | 327.00M | 324.00M | 315.00M | 322.00M | 298.00M |
| Selling, General & Admin | 1.12B | 1.11B | 1.04B | 1.03B | 1.04B | 1.13B | 1.03B | 1.07B | 1.04B | 1.15B | 996.00M | 1.07B |
| Operating Income | 515.00M | 827.00M | 653.00M | 654.00M | 629.00M | 801.00M | 676.00M | 608.00M | 540.00M | 689.00M | 617.00M | 570.00M |
| Interest Expense | 96.00M | 105.00M | 111.00M | 113.00M | 110.00M | 121.00M | 130.00M | 131.00M | 122.00M | 131.00M | 138.00M | 137.00M |
| Other Income (Expense) | 36.00M | 33.00M | 26.00M | -1.00M | 99.00M | 54.00M | 9.00M | 1.00M | -8.00M | 1.00M | 63.00M | 14.00M |
| Pretax Income | 505.00M | 821.00M | 643.00M | 613.00M | 692.00M | 834.00M | 658.00M | 578.00M | 512.00M | 609.00M | 636.00M | 570.00M |
| Income Tax | 94.00M | 219.00M | 179.00M | 113.00M | 104.00M | 96.00M | 168.00M | 143.00M | 124.00M | 193.00M | 250.00M | 137.00M |
| Net Income | 389.00M | 589.00M | 446.00M | 486.00M | 564.00M | 721.00M | 470.00M | 428.00M | 374.00M | 403.00M | 375.00M | 418.00M |
| Net Income growth (YoY) | -31.03% | -18.31% | -5.11% | +13.55% | +50.80% | +78.91% | +25.33% | +2.39% | +0.54% | -27.26% | -23.00% | -13.81% |
| EPS (Basic) | 0.85 | 1.29 | 0.98 | 1.06 | 1.23 | 1.58 | 1.03 | 0.94 | 0.82 | 0.89 | 0.82 | 0.92 |
| EPS (Diluted) | 0.85 | 1.28 | 0.98 | 1.06 | 1.23 | 1.58 | 1.02 | 0.93 | 0.81 | 0.89 | 0.82 | 0.91 |
| Shares Outstanding (Basic) | 456.00M | — | 456.00M | 457.00M | 457.00M | — | 457.00M | 457.00M | 456.00M | — | 455.00M | 455.00M |
| Shares Outstanding (Diluted) | 457.00M | — | 457.00M | 458.00M | 459.00M | — | 459.00M | 459.00M | 459.00M | — | 458.00M | 458.00M |
| EBITDA | 593.00M | 901.00M | 728.00M | 726.00M | 695.00M | 866.00M | 742.00M | 677.00M | 608.00M | 749.00M | 681.00M | 633.00M |
| Gross Margin | 38.53% | 39.68% | 38.69% | 39.64% | 42.12% | 42.77% | 41.66% | 41.37% | 40.90% | 41.41% | 40.13% | 40.27% |
| Operating Margin | 10.04% | 14.51% | 12.70% | 13.06% | 13.17% | 15.06% | 13.90% | 12.56% | 11.61% | 13.23% | 12.80% | 11.83% |
| Net Margin | 7.58% | 10.34% | 8.67% | 9.71% | 11.81% | 13.56% | 9.66% | 8.84% | 8.04% | 7.74% | 7.78% | 8.68% |
This table shows 12 quarterly periods of GE HealthCare Technologies's income statement, from Q1 2026 back to Q2 2023, across 19 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow GEHC's reporting calendar. What is a income statement?